| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,540,000 |
| Market
Cap: |
346.61(M) |
| Last
Volume: |
34,905,322 |
Avg
Vol: |
12,600,109 |
| 52
Week Range: |
$4.1 - $4.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Mark Robert |
CEO |
• • – |
2013-03-27 |
4 |
AB |
$5.31 |
$3,458 |
D/D |
650 |
161,141 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2013-02-27 |
4 |
AB |
$2.71 |
$3,434 |
D/D |
1,262 |
160,491 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2013-01-22 |
4 |
AB |
$2.82 |
$3,429 |
D/D |
1,215 |
159,229 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-12-26 |
4 |
AB |
$3.01 |
$3,437 |
D/D |
1,142 |
158,014 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-11-28 |
4 |
AB |
$2.12 |
$3,419 |
D/D |
1,607 |
156,872 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-11-19 |
4 |
B |
$1.96 |
$23,104 |
D/D |
11,800 |
155,265 |
2.81 |
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-11-16 |
4 |
B |
$1.82 |
$90,723 |
D/D |
49,793 |
143,465 |
2.81 |
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-11-15 |
4 |
B |
$1.69 |
$82,332 |
D/D |
48,833 |
93,672 |
2.81 |
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-10-24 |
4 |
AB |
$2.96 |
$3,434 |
D/D |
1,162 |
44,839 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-09-26 |
4 |
AB |
$3.32 |
$3,440 |
D/D |
1,036 |
43,677 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-08-22 |
4 |
AB |
$4.23 |
$3,451 |
D/D |
815 |
42,641 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-07-25 |
4 |
AB |
$10.04 |
$3,473 |
D/D |
346 |
41,826 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-07-02 |
4 |
AS |
$9.79 |
$9,790 |
D/D |
(1,000) |
35,050 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-07-02 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
36,050 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-06-27 |
4 |
AB |
$9.21 |
$3,477 |
D/D |
375 |
41,480 |
|
- |
|
| Olson William C |
Senior VP, Research and Develo |
• – – |
2012-06-20 |
4 |
D |
$8.69 |
$10,685 |
D/D |
(1,230) |
45,544 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-06-20 |
4 |
D |
$8.58 |
$28,604 |
D/D |
(3,333) |
35,050 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-06-01 |
4 |
AS |
$8.51 |
$8,508 |
D/D |
(1,000) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-06-01 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-05-23 |
4 |
AB |
$7.81 |
$3,475 |
D/D |
445 |
41,105 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-05-01 |
4 |
AS |
$10.93 |
$10,927 |
D/D |
(1,000) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-05-01 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-04-25 |
4 |
AB |
$9.92 |
$3,506 |
D/D |
348 |
40,660 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-04-02 |
4 |
AS |
$9.85 |
$9,852 |
D/D |
(1,000) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-04-02 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
|
- |
|
801 Records found
|
|
Page 3 of 33 |
|
|
